Anticoagulant Therapy in Difficult Patients with Atrial Fibrillation: When the Risks of Embolism and Bleeding Are Comparable

Anticoagulant Therapy in Difficult Patients with Atrial Fibrillation: When the Risks of Embolism and Bleeding Are Comparable

This article affects  the problems of using NOAC in the most defenseless groups  of patients with atrial fibrillation: those  who have high bleeding and high thromboembolic risk and elderly. The focus is on comparison of effectiveness and safety of NOACs based  on randomized clinical trials (RCT) an...

Full description

Bibliographic Details
Main Authors: D. A. Napalkov, A. A. Sokolova, M. A. Gabitova, L. N. Uddin
Format: Article
Language:English
Published: Stolichnaya Izdatelskaya Kompaniya 2018-11-01
Series:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:
atrial fibrillation
difficult patients
elderly
rivaroxaban
warfarin
Online Access:https://www.rpcardio.com/jour/article/view/1769

Internet

https://www.rpcardio.com/jour/article/view/1769

Similar Items